| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 137, 5000-5008, Copyright © 1996 by Endocrine Society
ARTICLES |
JB Schnermann, XL Zhu, X Shu, T Yang, YG Huang, M Kretzler and JP Briggs
Department of Physiology, University of Michigan, Ann Arbor 48109, USA. jbsch@umich.edu
Confluent cultures of two renal collecting duct cell lines (M-1 and mIMCD-K2 cells derived from cortical and inner medullary collecting ducts, respectively) express endothelin1 (ET1), transforming growth factor-beta (TGF beta; both TGF beta 1 and TGF beta 2), and both types of the TGF beta receptor. Experiments were performed to test whether endogenous TGF beta may be a paracrine modulator of ET1 expression in these cells. Treatment of M-1 and mIMCD-K2 cells with TGF beta 2 antisense oligodeoxynucleotides (ODN) significantly reduced ET1 messenger RNA (mRNA) and ET secretion (as well as TGF beta 2 mRNA) in a concentration-dependent manner, whereas control ODN were without significant effects. To produce ET inhibition, antisense ODN had to be present in the basolateral medium, whereas its sole presence in the apical medium was without effect. In addition, a pan-specific TGF beta antibody caused a significant reduction of ET1 mRNA expression and ET1 secretion. M-1 cells were found to express high levels of the mRNA for plasminogen activator of both tissue and urokinase types. Addition of the nonspecific serine protease inhibitor aprotinin (50 micrograms/ml) to the medium for 24 h significantly reduced the secretion of ET1. These results suggest that secretion of endogenous TGF beta, at least in part activated by the plasminogen/plasmin system, participates in the regulation of ET1 synthesis and secretion by collecting duct cell lines.
This article has been cited by other articles:
 |
|
 |
|
  J. M. Williams, X. Zhao, M. H. Wang, J. D. Imig, and D. M. Pollock Peroxisome Proliferator-Activated Receptor-{alpha} Activation Reduces Salt-Dependent Hypertension During Chronic Endothelin B Receptor Blockade Hypertension, August 1, 2005; 46(2): 366 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. F. Schrijvers, A. S. De Vriese, and A. Flyvbjerg From Hyperglycemia to Diabetic Kidney Disease: The Role of Metabolic, Hemodynamic, Intracellular Factors and Growth Factors/Cytokines Endocr. Rev., December 1, 2004; 25(6): 971 - 1010. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. C. Katwa Cardiac myofibroblasts isolated from the site of myocardial infarction express endothelin de novo Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H1132 - H1139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Shao, Z. Shi, P. J. Gotwals, V. E. Koteliansky, J. George, and D. C. Rockey Cell and Molecular Regulation of Endothelin-1 Production during Hepatic Wound Healing Mol. Biol. Cell, June 1, 2003; 14(6): 2327 - 2341. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Luchner, M. Jougasaki, E. Friedrich, D. D. Borgeson, T. L. Stevens, M. M. Redfield, G. A. J. Riegger, and J. C. Burnett Jr. Activation of cardiorenal and pulmonary tissue endothelin-1 in experimental heart failure Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2000; 279(3): R974 - R979. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. J. KELLY, S. ANDERSON, M. M. THOMPSON, T. T. OYAMA, T. M. KENNEFICK, C. L. CORLESS, R. J. ROMAN, L. KURTZBERG, B. M. PRATT, and S. R. LEDBETTER Acute and Chronic Renal Effects of Recombinant Human TGF-{beta}2 in the Rat J. Am. Soc. Nephrol., June 1, 1999; 10(6): 1264 - 1273. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. T. Eakes and M. S. Olson Regulation of endothelin synthesis in hepatic endothelial cells Am J Physiol Gastrointest Liver Physiol, June 1, 1998; 274(6): G1068 - G1076. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
